Skip to main content
The Journal of International Medical Research logoLink to The Journal of International Medical Research
. 2022 Nov 30;50(11):03000605221132028. doi: 10.1177/03000605221132028

Determinants of macrosomia among newborns delivered in northwest Ethiopia: a case–control study

Amanuel Adugna 1,, Yinager Workineh 2, Fikir Tadesse 3, Fentahun Alemnew 4, Nigatu Dessalegn 5, Kassa Kindie 6
PMCID: PMC9716614  PMID: 36448485

Abstract

Objective

Macrosomia is associated with the risk of mortality and morbidity in neonates and their mothers. Despite the considerable public health effect of macrosomia, evidence on the determinants of macrosomia is limited in Northwest Ethiopia in general and in Amhara region in particular. Therefore, this study aimed to identify determinants of macrosomia among newborns delivered in referral hospitals in 2020 in Amhara region, Northwest Ethiopia.

Methods

A facility-based unmatched case-control study was conducted among 279 mothers and their newborns in Amhara region referral hospitals. Newborns weighing 4000 g and above and between 2500 and 3999 g were considered cases and controls, respectively. Bivariable and multivariable binary logistic regression were used to identify the determinants of macrosomia.

Results

In total, 273 of 279 mothers and their newborns (97.8% response rate) were included. The mean birth weights of cases and controls were 4312.97 ± 357.53 g and 3161.92 ± 452.12 g, respectively. Weight gain over pregnancy, antenatal follow up, physical activity during pregnancy, and neonate sex were the main determinants of macrosomia.

Conclusion

The main determinants of macrosomia were determined in this study. Government should place special emphasis on reducing the modifiable factors of macrosomia.

Keywords: Amhara, birth weight, determinants, Ethiopia, macrosomia, newborns

Introduction

The term macrosomia can be defined in a variety of ways; considerable variation is observed in the minimum weight that defines macrosomia.13 Although absolute consensus on the definition has not been reached, most researchers from low- and middle-income countries define macrosomia as a birth weight of 4000 g or more that harms maternal and neonatal health outcomes.46

Worldwide, macrosomia affects 10% of pregnancies annually.7,8 In developed countries, the prevalence of fetal macrosomia ranges from 15% to 20%9 whereas the prevalence is between 2% and 9% in developing countries.5,9 Prevalence rates of 7.6% and 8% have been observed in Chad and Nigeria, respectively.10,11 In the Ethiopian context, studies in Mekelle and Hawassa indicate macrosomia rates of 6.6% and 11%, respectively.12,13

Maternal risk factors for macrosomia include high monthly income, full-term pregnancies, history of macrosomic newborns, pre-gestational body mass index (BMI), gestational weight gain (GWG), pre-existing diabetes mellitus, gestational diabetes mellitus, and multiple pregnancies.1,9,12,13 In addition, newborn sex and gestational age are recognized as independent neonatal factors for macrosomia.14 Studies conducted in Ethiopia identified gestational age, gestational diabetes mellitus, neonate sex, pre-gestational overweight, maternal age, and parity as notable factors.13,15,16

Macrosomia is associated with an increased risk of complications for both mothers and their neonates.4 For pregnant women, delivery of macrosomia is associated with significantly elevated risks of dysfunctional uterine contractions, prolonged labor, cesarean section, uterine rupture, postpartum hemorrhage, chorioamnionitis, and lower genital tract lacerations.17 For newborns, macrosomia increases the risks of shoulder dystocia, birth trauma, respiratory distress, meconium aspiration, birth asphyxia, perinatal infection, hypoglycemia, polycythemia, and hypoxic-ischemic encephalopathy and increases the need for admission to the neonatal intensive care unit.2,5 In addition, macrosomia increases the risk of developing cardiovascular disorders, obesity, and insulin resistance in adulthood.17,18 Lastly, macrosomia may produce a higher risk of psychiatric problems for babies in adulthood and mothers.19

The Ethiopian federal Minister of Health has implemented various strategies to enhance maternal and neonatal health, including expanding healthcare facilities and increasing the availability of supplies and skilled health professionals.20 Despite these actions, maternal and neonatal mortality rates remain at 412 per 100,000 and 29 per 1000 live births, respectively.21 Macrosomia remains a significant factor in maternal and neonatal mortality and morbidity in Ethiopia.5,15,22 Although the several risk factors of macrosomia in Ethiopia have been assessed, the evidence on the determinants of macrosomia—especially that of the modifiable risk factors at the country level in general and in the study area in particular—remains limited. Physical activity before and during pregnancy, BMI, GWG, and iron–folic acid supplementation are modifiable risk factors that have not been addressed by prior research in Ethiopia. Therefore, the study aimed to identify the determinants of macrosomia among newborns delivered in referral hospitals in Amhara region (Figure 1).

Figure 1.

Figure 1.

Conceptual framework for the determinants of macrosomia adapted from various studies.5,12,13,16,2325

Methods

Study design

A facility-based unmatched case-control study was conducted.

Study setting

The study was conducted at referral hospitals in Amhara regional state, Ethiopia from February 2020 to May 2020. According to a 2017 Ethiopian central statistical agency estimate, the regional state has a population of over 20 million, with equal representation of the sexes. Urban residents represent 12% of the population (below the national average) and roughly 91.4% of the regional state population is Amhara in ethnicity.26 Bahir Dar, the capital city of the regional state, is located 563 km from Northwest Addis Ababa, the capital city of Ethiopia.

Six referral hospitals are located in the regional state: the University of Gondar Referral Hospital (UGRH), Felege Hiwot Referral Hospital (FHRH), Tibebe Ghion Referral Hospital, Dessie Referral Hospital (DRH), Debre Markos Referral Hospital, and Debre Birhan Referral Hospital. The study was conducted simultaneously at three (FHRH, UGRH, and DRH) of these referral hospitals using the simple random sampling (lottery) method. These hospitals provide emergency obstetric care, maternal and neonatal health infrastructures, and a full complement of skilled health professionals including obstetricians, anesthesiologists, radiologists, neonatologists, nurses, and midwives. A total of 1960 health professionals (730 in FHRH, 670 in UGRH, and 560 in DRH) work in the selected hospitals.

A proportional sample allocation was applied to each hospital based on delivery data from the previous year. A total of 279 mothers and their newborns (93, 102, and 84 from FHRH, UGRH, and DRH, respectively) participated in the study. Participants were recruited within 12 hours of delivery in a labor or delivery room and were classified as cases or controls within one hour of delivery. Two controls were recruited for each case until the required sample size was reached at each hospital.

Participants

The study population consisted of mothers and their newborn babies who were delivered at selected Amhara region referral hospitals in the study period. Cases and controls were newborn babies who weighed 4000 g or more and between 2500 and 3999 g, respectively. Newborns with congenital anomalies, multiple births, newborns who were not weighed within the first hour of life, mothers with diabetes mellitus, and mothers who were too critically ill were excluded from the study. Permission and a supporting letter were obtained from Bahir Dar University, Ethiopia before data collection. The study was approved by an ethics review committee at Bahir Dar University. Confidentiality was assured and written consent/assent was obtained from all respondents.

Variables

Dependent variable

Macrosomia.

Independent variables

Sociodemographic factors: Maternal age, educational status, religious affiliation, marital status, residence, occupational status, and economic status.

Obstetric, lifestyle, and anthropometric factors: Antenatal follow up, parity, iron–folic acid supplementation, history of macrosomia, physical activity before pregnancy, physical activity during pregnancy, GWG, and BMI.

Newborn-related factors: Newborn sex and gestational age at delivery.

Case definitions

Macrosomia: A birth weight of 4000 g or more.

First-trimester weight: A pregnant woman’s weight during the first 12 weeks.

Third-trimester weight: A pregnant woman’s weight after 24 weeks.

Physically active during pregnancy: Mothers with a history of regular exercise such as walking, swimming, stationary cycling, running, marching, total body workout at a gymnasium, exercise ball workouts, or home gymnastics for 30 minutes or more per day during the current pregnancy.27

Sample size determination

The sample size was determined using a double population proportion formula in EpiInfo Version 7 statistical software by considering a 95% confidence interval (CI) and assuming a power of 80% and a case-to-control ratio of 1:2. Given that a previous study reported that newborn sex, gestational age, and a history of macrosomic newborns were significantly associated with macrosomia,13 all of these variables were considered when calculating sample size. Based on the adjusted odds ratio (AOR) of 2.2 for newborn sex and assuming that 54.7% and 74.6% of controls and cases, respectively, were exposed, the maximum sample size was estimated. After adding 10% for the non-response rate, 93 cases and 186 controls (i.e., a total sample size of 279) were included in the study.

The formula for the sample size was

n1=

Zα/2(1+1r)p(1p) + Zβp11p1 + p2(1p2)r2p1p22,

where n1 = the sample size required in each group, Zα/2 represented the desired level of statistical significance (1.96) for a 0.05 significance level, r was the ratio of cases to control (2:1), Zβ was the desired study power (typically 0.84 for 80% power), P was the average proportion (64.65%), p1 was the proportion of exposure in the control group in the reference study (54.7%), and p2 was the proportion of those exposed in the case group in the reference study (74.6%).

Data sources and measurement

The structured questionnaire and extraction checklist were adapted from previous literature.5,12,13,15,16,2325 Data were collected by interviewing the mother, reviewing medical records, and measuring the anthropometry of the mother and newborn baby.

An interviewer-administered questionnaire was used to collect information on the wealth index, maternal age, religion, marital status, occupation, educational level, and place of residence. Physical activity before and during pregnancy was reported by the mother using an interviewer-administered questionnaire.

Data on iron–folic acid supplements, parity, antenatal follow up, first-trimester weight, third-trimester weight, and history of macrosomia were extracted from the antenatal follow-up record using an extraction checklist. Data on gestational age at delivery were further collected using an extraction checklist from the antenatal follow-up chart. When information could not be ascertained, evidence from first or second-trimester ultrasound was used and respondents were then classified into pre-term, term, and post-term.

Newborns were weighed within 1 hour of birth using a digital scale to the nearest 1 g. Maternal height was calculated to the nearest 0.01 m using a wall height measurement. Mothers were asked to maintain an upright position with their feet together and a horizontal headpiece was lowered onto their heads. Pre-pregnancy BMI was calculated using first-trimester weight in kilograms divided by height in meters squared (kg/m2) then divided into three categories based on Centers for Disease Control guidelines: underweight (<18.5 kg/m2), normal (18.5 to <25 kg/m2), and overweight (>25 kg/m2 and above).28 GWG was calculated by subtracting first-trimester weight from the last third-trimester weight measurement and was categorized as low weight gain, normal weight gain, and excessive weight gain based on Institute of Medicine guidelines, which are accepted by the American College of Obstetricians and Gynecologists.29

Data quality control

Data were collected using questionnaires and checklists that were written in English and translated into Amharic. Six registered midwives (i.e., with a Bachelor of Science in Midwifery) were trained on techniques for data collection. The principal researchers were also involved in data collection. The pretest was conducted outside of the study area and the questionnaire and checklist were improved to meet the research objective. The birth weight of every newborn was measured within 1 hour of delivery using a similar, pre-calibrated digital scale balance. The study is reported according to the relevant Equator network guideline.30

Data processing and analysis

The data were cleaned, coded, and entered into EpiData version 3.2 (EpiData, Buenos Aires, Argentina) and transferred to SPSS, Version 25.0 (IBM Corp., Armonk, NY, USA) for analysis. The study variable was summarized using descriptive statistics such as frequency and percentage. The differences in the proportions of the characteristics between cases and controls were compared using the χ2 test. Bivariable and multivariable logistic regression models were used to test the associations between dependent and independent variables. Variables with a p-value ≤0.25 in the binary logistic regression were considered candidate variables for the multivariable logistic regression model. The main assumptions of the logistic regression model (i.e., the absence of outliers and multicollinearity) were checked. Accordingly, none of the interaction terms showed statistical significance, indicating the absence of a significant modification effect. Multicollinearity between the independent variables was evaluated using multiple linear regressions. No evidence of multicollinearity was identified given that the variance inflation factor for all variables was less than 10 and the tolerance statistic was greater than 0.1. The Hosmer–Lemeshow test was used to evaluate the fitness of the logistic regression model; a value of χ2 = 2.21, df = 8, (p = 0.974) indicated the model’s fitness. The model explained that 78.6% of the variation in the outcome and 78.4% of the variables were correctly classified. The strength of association between macrosomia and the determinants was assessed using AORs with 95% CIs. A statistically significant association was declared when the p-value was less than 0.05 in the multivariable regression analysis.

Results

Sociodemographic, obstetric, neonatal, anthropometric, and lifestyle characteristics

A total of 273 mothers and their newborns (91 cases and 182 controls) were included in the study and represented a response rate of 97.8%. The mean birth weight of cases was 4312.97 ± 357.53 g and that of controls was 4312.97 ± 357.53 g (p < 0.001). The mean gestational age at birth was 38.8 ± 2.54 weeks (p < 0.001). The proportion of mothers aged 35 years and above tended to be higher among cases (41.8%) compared with controls (21.4%; p = 0.002). In addition, the proportion of mothers with a middle wealth index tended to be lower among cases (13.2%) compared with that of controls (28.0%; p = 0.037). However, no significant differences were observed between case and control groups for maternal religious affiliation, marital status, level of educational), residence, and occupation (Table 1).

Table 1.

Sociodemographic characteristics in macrosomia and controls.

Variable Category CasesN = 91 (%) ControlsN = 182 (%) Chi-square(χ2) p-value
Maternal age (years) 15–24 25 (27.5) 70 (38.5) 0.895 0.827
25–34 28 (30.8) 73 (40.1)
≥35 38 (41.8) 39 (21.4)
Religion Orthodox Christian 63 (69.2) 120 (65.9) 0.650 0.883
Muslim 16 (17.6) 38 (20.9)
Catholic Christian 6 (6.6) 10 (5.5)
Protestant Christian 6 (6.6) 14 (7.7)
Marital status Single 8 (8.8) 11 (6.0) 0.895 0.827
Married 67 (73.6) 134 (73.6)
Divorced 9 (9.9) 21 (11.5)
Windowed 7 (7.7) 16 (8.8)
Wealth Index Poorest 16 (17.6) 39 (21.4) 10.210 0.037
Poorer 21 (23.1) 33 (18.1)
Middle 12 (13.2) 51 (28.0)
Richer 17 (18.7) 26 (14.3)
Richest 25 (27.5) 33 (18.1)
Occupation Homemaker 39 (42.9) 67 (36.8) 1.246 0.536
Government employee 20 (22.0) 39 (21.4)
Private worker 32 (35.2) 76 (41.8)
Educational level Unable to read and write 27 (29.7) 58 (31.9) 1.418 0.701
Primary 21 (23.1) 43 (23.6)
Secondary 20 (22.0) 46 (23.3)
Collage and above 23 (25.3) 35 (19.2)
Residence Rural 61 (65.6) 120 (65.9) 0.000 0.556
Urban 32 (34.4) 62 (34.1)

The proportion of mothers with a history of macrosomia tended to be higher among cases (38.5%) compared with controls (12.1%; p < 0.001) whereas the proportion of mothers with antenatal follow up tended to be lower among cases (80.2%) compared with controls (94.0%; p = 0.001). Moreover, the proportion of primipara mothers tended to be lower among cases (18.7%) compared with controls (35.2%; p = 0.012). Post-term pregnancy also tended to be higher for cases (26.4%) than for controls (12.4%; p = 0.009). Furthermore, female neonate sex was significantly lower for cases (47.3%) than for controls (72.0%; p < 0.001). However, significant differences were not observed between case and control groups in iron–folic acid supplementation and the frequency of antenatal follow up (Table 2).

Table 2.

Obstetric and neonatal factors in macrosomia and controls.

Variable Category CasesN = 91 (%) ControlsN = 182 (%) Chi-square(χ2) p-value
History of macrosomia Yes 35 (38.5) 22 (12.1) 25.544 <0.001
No 56 (61.5) 160 (87.9)
Parity 1 17 (18.7) 64 (35.2) 8.821 0.012
2–4 54 (59.3) 93 (51.1)
5 and above 20 (22.0) 25 (13,7)
ANC follow up Yes 73 (80.2) 171 (94.0) 12.057 0.001
No 18 (19.8) 11 (6.0)
Iron–folic acid supplementation Yes 54 (59.3) 97 (53.3) 0.897 0.207
No 37 (40.7) 85 (46.7)
Frequency of ANC follow up <4 times 32 (35.2) 63 (34.6) 0.008 0.516
>4 times 59 (64.8) 119 (65.4)
Gestational age at delivery Pre-term 22 (24.2) 62 (34.1) 9.500 0.009
Term 45 (49.5) 98 (53.8)
Post-term 24 (26.4) 22 (12.1)
Neonate sex Male 48 (52.7) 51 (28.0) 16.760 <0.001
Female 43 (47.3) 131 (72.0)

ANC: antenatal care.

The proportion of mothers who practiced pre-pregnancy physical activity tended to be lower among cases (69.2%) compared with controls (90.1%; p < 0.001) and the proportion of mothers who practiced physical activity during pregnancy tended to be lower among cases (51.6%) compared with controls (81.9%; p < 0.001). Moreover, the proportion of mothers who were overweight or obese based on pre-pregnancy BMI tended to be higher among cases (26.4%) compared with controls (8.8%; p < 0.001). Finally, the proportion of mothers with excessive GWG tended to be higher for cases (54.9%) than for controls (29.1%; p < 0.001; Table 3).

Table 3.

Anthropometric and lifestyle characteristics in macrosomia and controls.

Variables Category CasesN = 91 (%) ControlsN = 182 (%) Chi-square(χ2) p-value
Pre-pregnancy physical activity <30 min/day 28 (30.8) 18 (9.9) 18.876 <0.001
>30 min/day 63 (69.2) 164 (90.1)
Physical activity during pregnancy <30 min/day 44 (48.4) 33 (18.1) 27.360 <0.001
>30 min/day 47 (51.6) 149 (81.9)
Pre-pregnancy body mass index Underweight 9 (9.9) 28 (15.4) 15.386 <0.001
Normal weight 58 (63.7) 138 (75.8)
Overweight and obese 24 (26.4) 16 (8.8)
Weight gain during pregnancy (kg) Low weight gain 17 (10.7) 65 (35.7) 18.038 <0.001
Normal weight gain 24 (26.4) 64 (35.2)
Excessive weight gain 50 (54.9) 53 (29.1)

Determinants of macrosomia

In the bivariable logistic regression model, maternal age, wealth index, parity, history of macrosomia, pre-pregnancy physical activity, physical activity during pregnancy, antenatal follow up, GWG, pre-pregnancy BMI, gestational age at delivery, and neonate sex were the main determinants of macrosomia. After adjusting for confounding variables in a multivariable logistic regression model, GWG, antenatal follow up, physical activity during pregnancy, and neonate sex were independent determinants of macrosomia.

Neonates born from mothers who had excessive GWG were 3.5 times more likely to be macrosomic than their counterparts (AOR = 3.54; 95% CI: 1.52–8.23). Newborns of mothers who had no history of antenatal visits were at 3.2 times greater risk of having macrosomia compared with mothers who attended at least one antenatal visit (AOR = 3.21; 95% CI: 1.13–9.12). The risk of having a macrosomic newborn was higher among physically inactive mothers (<30 minutes of exercise/day) compared with their counterparts (AOR = 2.17; 95% CI: 1.09–4.70). The odds of experiencing macrosomia were higher among male neonates compared with female neonates (AOR = 2.07; 95% CI: 1.06–4.03; Table 4).

Table 4.

Bivariable and multivariable analysis of the determinants of macrosomia.

Variable Category CasesN = 91 (%) ControlsN = 182 (%) COR(95% CI) AOR(95% CI) p-value
Maternal age (years) 15–24 25 (27.5) 70 (38.5) 1
25–34 28 (30.8) 73 (40.1) 2.18 (1.16–4.10) 0.82 (0.36–1.86) 0.640
≥35 38 (41.8) 39 (21.4) 3.01 (1.36–6.66) 1.28 (0.44–3.68) 0.643
Wealth Index Poorest 16 (17.6) 39 (21.4) 1
Poorer 21 (23.1) 33 (18.1) 1.55 (0.69–3.44) 2.20 (0.80–6.07) 0.126
Middle 12 (13.2) 51 (28.0) 0.57 (0.24–1.35) 0.76 (0.27–2.18) 0.621
Richer 17 (18.7) 26 (14.3) 1.59 (0.68–3.70) 2.05 (0.70–5.98) 0.186
Richest 25 (27.5) 33 (18.1) 1.84 (0.84–4.02) 2.51 (0.94–6.70) 0.066
Parity Primiparity 17 (18.7) 64 (35.2) 1
Multiparity 54 (59.3) 93 (51.1) 2.18 (1.16–4.10) 1.21 (0.55–2.65) 0.626
Grandmultiparity 20 (22.0) 25 (13.7) 3.01 (1.36–6.66) 0.65 (0.17–2.42) 0.525
History of macrosomia Yes 35 (38.5) 22 (12.1) 4.54 (2.46–8.39) 2.17 (0.95–4.97) 0.065
No 56 (61.5) 160 (87.9) 1
ANC follow up Yes 73 (80.2) 171 (94.0) 1
No 18 (19.8) 11 (6.0) 3.83 (1.72–8.51) 3.21 (1.13–9.12) 0.028*
Pre-pregnancy physical activity <30 min/day 28 (30.8) 18 (9.9) 4.04 (2.04–7.83) 2.25 (0.93–5.41) 0.069
>30 min/day 63 (69.2) 164 (90.1) 1
Physical activity during pregnancy <30 min/day 44 (48.4) 33 (18.1) 4.22 (2.42–7.38) 2.17 (1.09–4.70) 0.047*
>30 min/day 47 (51.6) 149 (81.9) 1
Weight gain during pregnancy (kg) Low 17 (10.7) 65 (35.7) 1
Normal 24 (26.4) 64 (35.2) 1.43 (0.70–2.91) 1.93 (0.80–4.63) 0.139
Excessive 50 (54.9) 53 (29.1) 3.60 (1.86–6.97) 3.54 (1.52–8.23) 0.003*
Pre-pregnancy body mass index Underweight 9 (9.9) 28 (15.4) 1
Normal weight 58 (63.7) 138 (75.8) 1.30 (0.58–2.94) 1.54 (0.54–4.36) 0.408
Overweight and obese 24 (26.4) 16 (8.8) 4.66 (1.74–12.45) 3.1 (0.89–10.83) 0.075
Gestational age at delivery Pre-term 22 (24.2) 62 (34.1) 1
Term 45 (49.5) 98 (53.8 1.29 (0.71–2.36) 1.66 (0.77–3.58) 0.108
Post-term 24 (26.4) 22 (12.1) 3.07 (1.44–6.54) 2.00 (0.74–5.41) 0.171
Neonate sex Male 48 (52.7) 51 (28.0) 2.86 (1.69–4.84) 2.07 (1.06–4.03) 0.031*
Female 43 (47.3) 131 (72.0) 1

*Significant at ≤5%. COR: crude odds ratio, ANC: antenatal care, AOR: adjusted odds ratio 1: Reference.

Discussion

A commitment to protecting maternal and neonatal health is necessary for ensuring Ethiopia achieves the United Nations’ Sustainable Development Goals.31 Macrosomia and its consequences are factors that contribute to neonatal and maternal morbidity and mortality. Our study explored the determinants of macrosomia among newborns delivered in Amhara region referral hospitals in Northwest Ethiopia.

In the study, GWG was observed to have a significant effect on macrosomia. Mothers with excessive GWG were 3.5 times more likely to deliver macrosomic newborns than mothers with low GWG. This finding is consistent with those of studies in Nigeria, China, and Brazil.23,32,33 A possible explanation could be that excessive GWG is associated with decreased insulin sensitivity, which facilitates the transfer of glucose via the placenta to the growing fetus and leads to increased birth weight.34 Additionally, a 1-kg gain in maternal pregnancy weight is expected to increase neonatal birth weight by 94 g.35,36

The study further indicated that antenatal follow ups have a significant protective effect against macrosomia. Mothers who did not have any antenatal visits were 3.3 times more likely to have macrosomic neonates than mothers who attended at least one antenatal visit. This finding is similar to that of a study in the United States.37 A possible reason is that antenatal follow up is a cost-effective health promotion and preventive healthcare service that offers early detection and the treatment of pre-existing diseases and complications, ensuring healthy outcomes for the mother and newborn.37

A lack of physical activity during pregnancy had a significant association with macrosomia in the study. Newborns from physically inactive mothers (<30 min of exercise/day) were 2.1 times more likely to be macrosomic than their counterparts. This finding is supported by studies conducted in Spain and Canada.38,39 A low level of physical activity during pregnancy may result in GWG and may increase the risk of macrosomia. Physical activity during pregnancy has been shown to reduce maternal storage adiposity and fetal fat; therefore, it may prevent excessive GWG and promote healthy birth weight.40 Furthermore, exercise “steals” cardiac output from the womb and placenta and decreases the risk of macrosomia without increasing birth weight.41

Finally, a key determinant of macrosomia was newborn sex. Male newborns were twice more likely to be macrosomic than female neonates. This result is consistent with those of studies conducted in Gondar, Ethiopia; Hawassa, Ethiopia; Cameroon; Iran; and China.12,15,4244 and may be attributable to the greater weight and length of male newborns compared with female neonates.45,46 However, this finding was inconsistent with that of a Saudi Arabian study, which concluded that the rate of macrosomia was higher in female than in male neonates.47 This may be due to methodological differences given that the latter was a descriptive study.

One strength of this study is that given that the study included primary data, secondary data, and anthropometry measurements, several variables were included that had not been previously investigated in a study setting. In addition, cases and controls were enrolled by accurately measuring newborn weight within 1 hour of delivery to avoid discrepancies.

This study had some limitations. Our research might have been subject to recall bias; however, we used strategies—careful selection of the study question and employment of local data collectors familiar with the community culture—that might have reduced recall bias. Another study limitation was the use of first-trimester weight information recorded on the antenatal chart as a proxy for pre-pregnancy weight, which might have led to misclassification bias. However, we believe this bias was negligible given that GWG occurs largely in the third trimester.48

Conclusion

Determinants of macrosomia were identified in this study. GWG, physical activity during pregnancy, and antenatal follow up were the modifiable determinants of macrosomia, whereas newborn sex was a non-modifiable factor of macrosomia. Accordingly, the government must place special emphasis on reducing the modifiable factors of macrosomia.

Acknowledgements

We would like to thank hospital managers, study participants, data collectors, and supervisors for their support of the overall research procedure.

Footnotes

The authors declare that there is no conflict of interest.

Funding: The authors received no financial support for the research, authorship, and publication of this study.

ORCID iDs

Amanuel Adugna https://orcid.org/0000-0002-1697-0533

Kassa Kindie https://orcid.org/0000-0002-2210-7605

References

  • 1.American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice bulletin no. 173: fetal macrosomia. Obstet Gynecol 2016; 128: e195–e209. [DOI] [PubMed] [Google Scholar]
  • 2.Ye J, Torloni MR, Ota E, et al. Searching for the definition of macrosomia through an outcome-based approach in low-and middle-income countries: a secondary analysis of the WHO Global Survey in Africa, Asia, and Latin America. BMC Pregnancy Childbirth 2015; 15: 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Salihu HM, Dongarwar D, King LM, et al. Trends in the incidence of fetal macrosomia and its phenotypes in the United States, 1971–2017. Arch Gynecol Obstet 2020; 301: 415–426. [DOI] [PubMed] [Google Scholar]
  • 4.Koyanagi A, Zhang J, Dagvadorj A, et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet 2013; 381: 476–483. [DOI] [PubMed] [Google Scholar]
  • 5.Said AS, Manji KP. Risk factors and outcomes of fetal macrosomia in a tertiary center in Tanzania: a case-control study. BMC Pregnancy Childbirth 2016; 16: 243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Usta A, Usta CS, Yildiz A, et al. Frequency of fetal macrosomia and the associated risk factors in pregnancies without gestational diabetes mellitus. Pan Afr Med J 2017; 26: 62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pavlov E, Dobrioglo I, Ciobanu V. Risk factors in the macrosomic fetus birth. 2013.
  • 8.Moll U. Pregnancy characteristics as risk factors for future maternal diabetes and other diseases: Lund University; 2019. [Google Scholar]
  • 9.Dennedy MC, Dunne F. Macrosomia: defining the problem worldwide. Lancet 2013; 9865: 435–436. [DOI] [PubMed] [Google Scholar]
  • 10.Kayode-Adedeji B, Egharevba O, Omoregbee H. Prevalence of fetal macrosomia and neonatal complications in a Nigerian suburban hospital: a five-year study. JPNIM 2018; 7: e070120. [Google Scholar]
  • 11.Madoue GB, Sile SN, Lhagadang F. Foetal macrosomia: risk factors, maternal and fetal outcomes in N'Djamena Mother and Child Hospital, Chad. South Sudan Medical Journal 2018; 11: 40–43. [Google Scholar]
  • 12.Mengesha HG, Wuneh AD, Weldearegawi B, et al. Low birth weight and macrosomia in Tigray, Northern Ethiopia: who are the mothers at risk? BMC Pediatr 2017; 17: 144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Biratu AK, Wakgari N, Jikamo B. Magnitude of fetal macrosomia and its associated factors at public health institutions of Hawassa city, southern Ethiopia. BMC Res Notes 2018; 11: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Koyanagi A, Zhang J, Dagvadorj A, et al. Macrosomia in 23 Developing Countries: An Analysis of a Multicountry, Facility-based, Cross-Sectional Survey. Obstetric Anesthesia Digest 2014; 34: 89. [DOI] [PubMed] [Google Scholar]
  • 15.Adugna DG, Enyew EF, Jemberie MT. Prevalence and associated factors of macrosomia among newborns delivered in the university of Gondar comprehensive specialized hospital, Gondar, Ethiopia: an institution-based cross-sectional study. Pediatric Health Med Ther 2020; 11: 495–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tela FG, Bezabih AM, Adhanu AK, et al. Fetal macrosomia and its associated factors among singleton live births in private clinics in Mekelle city, Tigray, Ethiopia. BMC Pregnancy Childbirth 2019; 19: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Schwartz N, Quant HS, Sammel MD, et al. Macrosomia has its roots in early placental development. Placenta 2014; 35: 684–690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Briana DD, Germanou K, Boutsikou M, et al. Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: the impact of gestational diabetes. J Matern Fetal Neonatal Med 2018; 31: 895–900. [DOI] [PubMed] [Google Scholar]
  • 19.Van Mil NH, Steegers-Theunissen RP, Motazedi E, et al. Low and high birth weight and the risk of child attention problems. J Pediatr 2015; 166: 862–869.e1-3. [DOI] [PubMed] [Google Scholar]
  • 20.WHO. WHO recommendations on antenatal care for a positive pregnancy experience: WHO; 2016. [PubMed]
  • 21.Central Statistical Agency [Ethiopia] and ICF. Ethiopia Demographic and Health Survey, Addis Ababa. Central Statistical Agency. 2016. [Google Scholar]
  • 22.Jasim SK, Al-Momen H, Majeed BA, et al. Rate of fetal macrosomia with maternal and early neonatal complications in internally moved people affected by violence. Int J Med Res Health Sci 2018; 7: 141–146. [Google Scholar]
  • 23.Akindele R, Audu L, Mokuolu O. Macrosomic births in Abuja: A case-control study of predisposing factors and early neonatal outcome. Niger J Clin Pract 2017; 20: 320–327. [DOI] [PubMed] [Google Scholar]
  • 24.Olokor OE, Onakewhor JU, Aderoba AK. Determinants and outcome of fetal macrosomia in a Nigerian tertiary hospital. Niger Med J 2015; 56: 411–415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mohammadbeigi A, Farhadifar F, Soufizadeh N, et al. Fetal macrosomia: risk factors, maternal, and perinatal outcome. Ann Med Health Sci Res 2013; 3: 546–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wubneh M. Addis Ababa, Ethiopia–Africa’s diplomatic capital. Cities 2013; 35: 255–269. [Google Scholar]
  • 27.Gregg VH, Ferguson JE 2nd. Exercise in pregnancy. Clin Sports Med 2017; 36: 741–752. [DOI] [PubMed] [Google Scholar]
  • 28.Waltrick R, Possamai DS, Aguiar FPD, et al. Comparison between a clinical diagnosis method and the surveillance technique of the Center for Disease Control and Prevention for identification of mechanical ventilator-associated pneumonia. Rev Bras Ter Intensiva 2015; 27: 260–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.McGuire S. IOM (Institute of Medicine) and NRC (National Research Council). 2013. Supplemental nutrition assistance program: examining the evidence to define benefit adequacy. Washington, DC: The National Academies Press, 2013. Adv Nutr 2013; 4: 477–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Erik von Elm M, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577. [DOI] [PubMed] [Google Scholar]
  • 31.Pigois R, Samson M, Vinci V. Achieving child-centred SDGs in Ethiopia: the potential of inter-sectoral synergies. What Works for Africa’s Poorest Children: From Measurement to Action Rugby, UK: Practical Action Publishing. 2020; 117–139.
  • 32.Czarnobay SA, Kroll C, Schultz LF, et al. Predictors of excess birth weight in Brazil: a systematic review. J Pediatr (Rio J) 2019; 95: 128–154. [DOI] [PubMed] [Google Scholar]
  • 33.Yang S, Zhou A, Xiong C, et al. Parental Body Mass Index, Gestational Weight Gain, and Risk of Macrosomia: a Population‐Based Case-Control Study in China. Paediatr Perinat Epidemiol 2015; 29: 462–471. [DOI] [PubMed] [Google Scholar]
  • 34.Vickers MH. Developmental programming and transgenerational transmission of obesity. Ann Nutr Metab 2014; 64: 26–34. [DOI] [PubMed] [Google Scholar]
  • 35.Murphy MM, Stettler N, Smith KM, et al. Associations of consumption of fruits and vegetables during pregnancy with infant birth weight or small for gestational age births: a systematic review of the literature. Int J Womens Health 2014; 6: 899–912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tela FG, Bezabih AM, Adhanu AK. Effect of pregnancy weight gain on infant birth weight among mothers attending antenatal care from private clinics in Mekelle City, Northern Ethiopia: A facility-based follow-up study. PloS one 2019; 14: e0212424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Su D, Samson K, Garg A, et al. Birth history as a predictor of adverse birth outcomes: Evidence from state vital statistics data. Prev Med Rep 2018; 11: 63–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Barakat R, Pelaez M, Cordero Y, et al. Exercise during pregnancy protects against hypertension and macrosomia: a randomized clinical trial. Am J Obstet Gynecol 2016; 214: 649.e1–e8. [DOI] [PubMed] [Google Scholar]
  • 39.World Health Organization. Report of a WHO technical consultation on birth spacing: Geneva, Switzerland; 13-15 June 2005. WHO, 2007. [Google Scholar]
  • 40.Bisson M, Croteau J, Guinhouya BC, et al. Physical activity during pregnancy and infant’s birth weight: results from the 3D Birth Cohort. BMJ Open Sport Exerc Med 2017; 3: e000242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wiebe HW, Boulé NG, Chari R, et al. The effect of supervised prenatal exercise on fetal growth: a meta-analysis. Obstet Gynecol 2015; 125: 1185–1194. [DOI] [PubMed] [Google Scholar]
  • 42.Mardani M, Khalkhalirad A, Rossta S, et al. Evaluation of the prevalence of macrosomia and the maternal risk factors. IJN 2014; 5: 5–9. [Google Scholar]
  • 43.Nkwabong E, Nzalli Tangho GR. Risk factors for macrosomia. J Obstet Gynaecol India 2015; 65: 226–229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ma R, Tsoi K, Tam W, et al. Developmental origins of type 2 diabetes: a perspective from China. Eur J Clin Nutr 2017; 71: 870–880. [DOI] [PubMed] [Google Scholar]
  • 45.Fazzi C, Saunders DH, Linton K, et al. Sedentary behaviours during pregnancy: a systematic review. Int J Behav Nutr Phys Act 2017; 14: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Catalano PM, Drago NM, Amini SB. Factors affecting fetal growth and body composition. Am J Obstet Gynecol 1995; 172: 1459–1463. [DOI] [PubMed] [Google Scholar]
  • 47.Qashar F, Al-Ghamdi M, Arab W, et al. Prevalence and outcomes of macrosomic infants born to non-diabetic mothers: A ten years experience at the tertiary care center. J Am Sci 2016; 12: 89. [Google Scholar]
  • 48.Chatfield JE. ACOG issues guidelines on fetal macrosomia. Am Fam Physician 2001; 64: 169–170. [PubMed] [Google Scholar]

Articles from The Journal of International Medical Research are provided here courtesy of SAGE Publications

RESOURCES